Literature DB >> 26949325

THE USE OF GLUTAMATE MODULATING DRUGS IN OBSESSIVE COMPULSIVE DISORDER.

Frank P MacMaster1, David R Rosenberg2.   

Abstract

Entities:  

Keywords:  Adolescents; Children; Glutamate; Obsessive-Compulsive Disorder; Serotonin

Year:  2010        PMID： 26949325      PMCID： PMC4776764          DOI： 10.1521/capn.2010.15.6.1

Source DB:  PubMed          Journal:  Child Adolesc Psychopharmacol News        ISSN： 1085-0295


× No keyword cloud information.
  27 in total

Review 1.  Clinical practice. Obsessive-compulsive disorder.

Authors:  Michael A Jenike
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

2.  Memantine for treatment-resistant OCD.

Authors:  Michael Poyurovsky; Ronit Weizman; Abraham Weizman; Lorrin Koran
Journal:  Am J Psychiatry       Date:  2005-11       Impact factor: 18.112

3.  N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder.

Authors:  Daniel L Lafleur; Christopher Pittenger; Ben Kelmendi; Tom Gardner; Suzanne Wasylink; Robert T Malison; Gerard Sanacora; John H Krystal; Vladimir Coric
Journal:  Psychopharmacology (Berl)       Date:  2005-12-22       Impact factor: 4.530

4.  Memantine as an augmenting agent for severe pediatric OCD.

Authors:  Dianne M Hezel; Katherine Beattie; S Evelyn Stewart
Journal:  Am J Psychiatry       Date:  2009-02       Impact factor: 18.112

5.  Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.

Authors:  Vladimir Coric; Sarper Taskiran; Christopher Pittenger; Suzanne Wasylink; Daniel H Mathalon; Gerald Valentine; John Saksa; Yu-Te Wu; Ralitza Gueorguieva; Gerard Sanacora; Robert T Malison; John H Krystal
Journal:  Biol Psychiatry       Date:  2005-09-01       Impact factor: 13.382

6.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

7.  Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.

Authors:  Jamie D Feusner; Lauren Kerwin; Sanjaya Saxena; Alexander Bystritsky
Journal:  Psychopharmacol Bull       Date:  2009

Review 8.  Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature.

Authors:  S E Stewart; D A Geller; M Jenike; D Pauls; D Shaw; B Mullin; S V Faraone
Journal:  Acta Psychiatr Scand       Date:  2004-07       Impact factor: 6.392

9.  Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report.

Authors:  O Uzun
Journal:  J Psychopharmacol       Date:  2008-11-14       Impact factor: 4.153

10.  D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.

Authors:  Matt G Kushner; Suck Won Kim; Christopher Donahue; Paul Thuras; David Adson; Michael Kotlyar; James McCabe; Jillian Peterson; Edna B Foa
Journal:  Biol Psychiatry       Date:  2007-06-22       Impact factor: 13.382
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.